Dementia: A crazy enigma
Keywords:
DementiaAbstract
.
References
GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet. Public Health 2022, 7, e105–e125.
Nucci D, Sommariva A, Degoni LM, et al. Association between Mediterranean diet and dementia and Alzheimer disease: a systematic review with meta-analysis. Aging Clin Exp Res 36, 77 (2024). https://doi.org/10.1007/s40520-024-02718-6.
Cucinotta D. Pharmacological treatment of dementias.. Lecture. Abstract Book. XXXVIIth Janez Plocnick Memorial Meeting, University of Ljubljana, Dec 7, 2006 (Slides are available on request).
Hendriks S, Peetoom K, Bakker C, et al. Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis. JAMA Neurol. 2021;78(9):1080–1090. doi:10.1001/jamaneurol.2021.2161.
Livingston G, Huntley J, Sommerlad A, et al.. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367.
van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29. PMID: 36449413.
Cummings J, Aisen P, Lemere C, Atri A, Sabbagh M, Salloway S. Aducanumab produced a clinically meaningful benefit in association with amyloid lowering. Alzheimers Res Ther. 2021 May 10;13(1):98. doi: 10.1186/s13195-021-00838-z. PMID: 33971962.
Knopman DS, Jones DT, Greicius MD. Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement. 2021 Apr;17(4):696-701. doi: 10.1002/alz.12213. .
Alzheimer Europe position on anti-amyloid therapies. https://www.alzheimer-europe.org/ policy/ positions/alzheimer-europe-position-anti-amyloid-therapies,2024 . www.alzheimer-europe.org: Public Call for Action, March 22,2024. www.alzheimer-europe.org: Public Call for Action, March 22,2024.
Altomare D, Barkhof F, Caprioglio C,; et al. Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium. Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial. JAMA Neurol. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamaneurol.2023.0997..
The Lancet Neurology. Dementia diagnosis in the anti-amyloid era. Lancet Neurol. 2024 Mar;23(3):219. doi: 10.1016/S1474-4422(24)00041-3.
Yaffe K, Vittinghoff E, Dublin S, et al. Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical Trial. JAMA Intern Med. Published online November 27, 2023. doi:10.1001/jamainternmed.2023.6279
Nien SW, Lin IH, Wu HC, Chen YH, Yang SC. Evaluation of Dietary Intake in Individuals with Mild Cognitive Impairment. Nutrients. 2023 Aug 23;15(17):3694. doi: 10.3390/nu15173694. PMID: 37686726; PMCID: PMC10490258.
Meshram A, Yadav D, Song M. Investigating the Mediterranean diet’s role in Alzheimer’s disease prevention: a review. Progr Nutr [Internet]. 2023 Dec. 13 [cited 2023 Dec. 15];25(4):e2023057.
Capurso A. The Mediterranean diet: a historical perspective. Aging Clin Exp Res.2024;36:78 (2024). https://doi.org/10.1007/s40520-023-02686-3.
Grabrucker S, Marizzoni M, Silajdžić E, et al. Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis. Brain. 2023 Dec 1;146(12):4916-4934. doi: 10.1093/brain/awad303. PMID: 37849234; PMCID: PMC10689930.
Morley JE. Editorial: Management of Cognitive Dysfunction. J Nutr Health Aging. 2021;25(7):819-820. doi: 10.1007/s12603-021-1654-y. PMID: 34409959.
Lin FR, Pike JR, Albert MS, et al.. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet. 2023 Sep 2;402(10404):786-797. doi: 10.1016/S0140-6736(23)01406-X.
New dementia strategy for Scotland: Everyone’s Story. Published on www.gov.scot/publications 31 May 2023
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Domenico Cucinotta
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
